Piramal Pharma Limited — Board Meeting, 23-10-2024: Outcome of Board Meeting

Piramal Pharma Limited announced its unaudited financial results for the quarter and half-year ending September 30, 2024. The company reported a total income of ₹1,390.77 crores, with a profit after tax of ₹210.06 crores. The results include a limited review by auditors. The company plans to publish its financial results in newspapers and provide additional information on its website. For further details, investors can visit piramalpharma.com.